Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Weiss, Glen
One or more keywords matched the following items that are connected to
Weiss, Glen
Item Type
Name
Concept
Checkpoint Kinase 1
Academic Article
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500?mg/m(2) every 21 days in patients with cancer.
Search Criteria
Checkpoint Kinase 1